Voyager Therapeutics VYGR
NASDAQ VYGR
$2.69 +0.05 (+1.89%)
As of: Sep 30, 2026 · 1:19 PM EDT

Voyager Therapeutics, Inc. (VYGR) EBITDA (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded EBITDA of -$25.48 million in Q2 2026, compared with -$35.56 million a year earlier.

Analysis

Voyager Therapeutics, Inc. (VYGR) EBITDA (2014 - 2026) Analysis & Trends

On a TTM basis, Voyager Therapeutics' EBITDA came in at -$113.33 million as of Jun 30, 2026; for FY2025, it came in at -$127.74 million.

  • Across earlier years, EBITDA came in at -$78.56 million in FY2024, $126.46 million in FY2023, -$44.64 million in FY2022 and -$68.42 million in FY2021.
  • The Q2 2026 figure is the highest quarterly EBITDA since Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$29.34 million (Q1 2026), -$28.84 million (Q4 2025) and -$29.66 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.48 Mn
Mar 31, 2026 -29.34 Mn
Dec 31, 2025 -28.84 Mn
Sep 30, 2025 -29.66 Mn
Jun 30, 2025 -35.56 Mn
Mar 31, 2025 -33.68 Mn
Dec 31, 2024 -37.29 Mn
Sep 30, 2024 -12.65 Mn
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 -14.99 Mn
Dec 31, 2023 55.40 Mn
Sep 30, 2023 -28.56 Mn
Jun 30, 2023 -24.34 Mn
Mar 31, 2023 123.96 Mn
Dec 31, 2022 -23.72 Mn
Sep 30, 2022 15.78 Mn
Jun 30, 2022 -18.16 Mn
Mar 31, 2022 -18.54 Mn
Dec 31, 2021 7.22 Mn
Sep 30, 2021 -23.92 Mn
API Access

Voyager Therapeutics, Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=VYGR&period=max&api_key=YOUR_API_KEY